Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myeloablative vs Non-Myeloablative Consolidation for Primary CNS B-cell Lymphoma
NCT01511562Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2012
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, thiotepa, cytarabine, etoposide in primary central nervous system lymphoma (PCNSL), sponsored by Cancer and Leukemia Group B. Started Sep 2012; status: completed.
02
Drugs
carmustinethiotepacytarabineetoposide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT01511562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511562.